A Strategy for Imidazotetrazine Prodrugs with Anti-cancer Activity Independent of MGMT and MMR

Article English OPEN
Garelnabi, EAE ; Pletsas, D ; Li, L ; Kiakos, K ; Karodia, N ; Hartley, JA ; Phillips, Roger ; Wheelhouse, RT (2012)
  • Publisher: ACS Publications
  • Subject: RM

The imidazotetrazine ring is an acid-stable precursor and prodrug of highly-reactive alkyl diazonium ions. We have shown that this reactivity can be managed productively in an aqueous system for the generation of aziridinium ions with 96% efficiency. The new compounds are potent DNA alkylators and have antitumor activity independent of the O6-methylguanine-DNA methyltransferase and DNA mismatch repair constraints that limit the use of temozolomide.
  • References (16)
    16 references, page 1 of 2

    1. Newlands, E. S.; Stevens, M. F. G.; Wedge, S. R.; Wheelhouse, R. T.; Brock, C. Temozolomide: a Review of its Discovery, Chemical Properties, Pre-clinical Development and Clinical Trials. Cancer Treatment Reviews 1997, 23, 35-61.

    2. Datamonitor. Commercial Insight: Cytotoxic Therapies. 2009.

    3. Wheelhouse, R. T.; Stevens, M. F. G. Decomposition of the Antitumour Drug Temozolomide in Deuteriated Phosphate Buffer: Methyl Group Transfer is Accompanied by Deuterium Exchange. J. Chem. Soc., Chem. Commun. 1993, 1177-1178.

    4. Denny, B. J.; Wheelhouse, R. T.; Stevens, M. F. G.; Tsang, L. L. H. NMR and Molecular Modeling Investigation of the Mechanism of Activation of the Antitumor Drug Temozolomide and its Interaction with DNA. Biochemistry 1994, 33, 9045-9051.

    5. Stevens, M. F. G.; Hickman, J. A.; Langdon, S. P.; Chubb, D.; Vickers, L.; Stone, R.; Baig, G.; Goddard, C.; Gibson, N. W.; Slack, J. A.; Newton, C.; Lunt, E.; Fizames, C.; Lavelle, F. Antitumor Imidazotetrazines 13. Antitumor Activity and Pharmacokinetics in Mice of 8-Carbamoyl-3-Methyl-Imidazo-[5,1-d]-1,2,3,5-tetrazin4(3H)-one (CCRG 81045-M&B-39831), a Novel Drug with Potential as an Alternative to Dacarbazine. Cancer Research 1987, 47, 5846- 5852.

    6. McGarrity, J. F.; Smyth, T. Hydrolysis of DiazomethaneKinetics and Mechanism. J. Am. Chem. Soc. 1980, 102, 7303-7308.

    7. Wang, Y.; Wheelhouse, R. T.; Zhao, L.; Langnel, D. A. F.; Stevens, M. F. G. Antitumour Imidazotetrazines. Part 36. Conversion of 5-aminoimidazole-4-carboxamide to Imidazo-[5,1-d]-1,2,3,5- tetrazin4(3H)-ones and Imidazo-[1,5-a]-1,3,5-triazin4(3H)-ones Related in Structure to the Antitumour Agents Temozolomide and Mitozolomide. J. Chem. Soc., Perkin Trans. 1 1998, 1669-1676.

    8. Newlands, E. S.; Blackledge, G.; Slack, J. A.; Goddard, C.; Brindley, C. J.; Holden, L.; Stevens, M. F. G. Phase-I Clinical Trial of Mitozolomide. Cancer Treatment Reports 1985, 69, 801-805.

    9. Darkes, M. J. M.; Plosker, G. L.; Jarvis, B. Temozolomide a Review of its Use in the Treatment of Malignant Gliomas, Malignant Melanoma and Other Advanced Cancers Am. J. Cancer 2002, 1, 55-80

    10. D. Pletsas; R.T. Wheelhouse; V. Pletsa; A. Nicolaou; T.C. Jenkins; M.C. Bibby; Kyrtopoulos, S. A. Polar, Functionalized Guanine-O6 Derivatives Resistant to Repair by O6-AlkylguanineDNA Alkyltransferase: Implications for the Design of DNAmodifying Drugs. Eur. J. Med. Chem. 2006, 41, 330-339.

  • Metrics
    views in OpenAIRE
    views in local repository
    downloads in local repository

    The information is available from the following content providers:

    From Number Of Views Number Of Downloads
    University of Huddersfield Repository - IRUS-UK 0 36
Share - Bookmark